<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2077-8333/epi.par.con.2025.265</article-id><article-id custom-type="elpub" pub-id-type="custom">epilepsia-1257</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC SURVEYS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>Temporal epilepsy: contribution of molecular genetics to epileptogenesis mechanisms</article-title><trans-title-group xml:lang="ru"><trans-title>Височная эпилепсия: вклад молекулярной генетики в механизмы эпилептогенеза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7682-6672</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимова</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimova</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимова Марина Юрьевна, д.м.н., проф.</p><p>WoS ResearcherID: C-7408-2012</p><p>Scopus Author ID: 7003900736</p><p>Волоколамское ш., д. 80, Москва 125367</p></bio><bio xml:lang="en"><p>Marina Yu. Maksimova, Dr. Sci. Med., Prof.</p><p>WoS ResearcherID: C-7408-2012</p><p>Scopus Author ID: 7003900736</p><p>80 Volokolamskoe Shosse, Moscow 125367</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4449-8651</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Теплышова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Teplyshova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Теплышова Анна Михайловна, к.м.н. </p><p>Волоколамское ш., д. 80, Москва 125367</p></bio><bio xml:lang="en"><p>Anna M. Teplyshova, PhD </p><p>80 Volokolamskoe Shosse, Moscow 125367</p></bio><email xlink:type="simple">teplyshova@neurology.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное научное учреждение «Российский центр неврологии и нейронаук»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Center of Neurology and Neurosciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>15</day><month>01</month><year>2026</year></pub-date><volume>17</volume><issue>4</issue><fpage>402</fpage><lpage>409</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Maksimova M.Y., Teplyshova A.M., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Максимова М.Ю., Теплышова А.М.</copyright-holder><copyright-holder xml:lang="en">Maksimova M.Y., Teplyshova A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/1257">https://www.epilepsia.su/jour/article/view/1257</self-uri><abstract><p>Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy. The mechanisms of epileptogenesis in TLE involve a wide range of neurobiological, biochemical, genomic, epigenetic, and transcriptomic changes. Together, these processes lead to morphofunctional reorganization of neural networks and the onset of spontaneous seizures. Neuroinflammation (involving glia activation and cytokine release), neural network remodeling, impaired signal transmission, and loss of inhibitory interneurons play a prominent role in epileptogenesis. Hippocampus transcriptomic studies have revealed a wide range of involved genes, highlighting the importance for interplay between genetic predisposition and acquired factors in developing this disease. The review presents current views on the neurobiological and molecular genetic basis of TLE-related epileptogenesis.</p></abstract><trans-abstract xml:lang="ru"><p>Височная эпилепсия (ВЭ) – наиболее распространенная форма фокальной эпилепсии. Механизмы эпилептогенеза при ВЭ включают широкий спектр нейробиологических, биохимических, геномных, эпигеномных и транскриптомных изменений. В совокупности эти процессы приводят к морфофункциональной перестройке нейронных сетей и возникновению спонтанных приступов. Значительную роль в эпилептогенезе играют нейровоспаление (с активацией глии и выбросом цитокинов), ремоделирование нейронных сетей, нарушение передачи сигналов и потеря тормозных интернейронов. Транскриптомные исследования гиппокампа выявили широкий спектр вовлеченных генов, что подчеркивает важность взаимодействия генетической предрасположенности и приобретенных факторов в развитии этого заболевания. В обзоре представлены современные взгляды на нейробиологические и молекулярно-генетические основы эпилептогенеза при ВЭ.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фокальная эпилепсия</kwd><kwd>медиальная височная эпилепсия</kwd><kwd>эпилептогенез</kwd><kwd>молекулярная генетика</kwd><kwd>факторы транскрипции</kwd></kwd-group><kwd-group xml:lang="en"><kwd>focal epilepsy</kwd><kwd>mesial temporal lobe epilepsy</kwd><kwd>epileptogenesis</kwd><kwd>molecular genetics</kwd><kwd>transcription factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Neumann A.M., Britsch S. Molecular genetics of acquired temporal lobe epilepsy. Biomolecules. 2024; 14 (6): 669. https://doi.org/10.3390/biom14060669.</mixed-citation><mixed-citation xml:lang="en">Neumann A.M., Britsch S. Molecular genetics of acquired temporal lobe epilepsy. Biomolecules. 2024; 14 (6): 669. https://doi.org/10.3390/biom14060669.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Deleu B., Jeuris J., Van Paesschen W. The interacting etiologies of hippocampal sclerosis in epilepsy: a scoping review. Epilepsia. 2025; Oct 17. https://doi.org/10.1111/epi.18676.</mixed-citation><mixed-citation xml:lang="en">Deleu B., Jeuris J., Van Paesschen W. The interacting etiologies of hippocampal sclerosis in epilepsy: a scoping review. Epilepsia. 2025; Oct 17. https://doi.org/10.1111/epi.18676.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Piñero J., Ramírez-Anguita J.M., Saüch-Pitarch J., et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020; 48 (D1): D845–55. https://doi.org/10.1093/nar/gkz1021.</mixed-citation><mixed-citation xml:lang="en">Piñero J., Ramírez-Anguita J.M., Saüch-Pitarch J., et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020; 48 (D1): D845–55. https://doi.org/10.1093/nar/gkz1021.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Łukasiuk K., Lasoń W. Emerging molecular targets for antiepileptogenic and epilepsy modifying drugs. Int J Mol Sci. 2023; 24 (3): 2928. https://doi.org/10.3390/ijms24032928.</mixed-citation><mixed-citation xml:lang="en">Łukasiuk K., Lasoń W. Emerging molecular targets for antiepileptogenic and epilepsy modifying drugs. Int J Mol Sci. 2023; 24 (3): 2928. https://doi.org/10.3390/ijms24032928.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zattoni M., Mura M.L., Deprez F., et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci. 2011; 31 (11): 4037–50. https://doi.org/10.1523/JNEUROSCI.6210-10.2011.</mixed-citation><mixed-citation xml:lang="en">Zattoni M., Mura M.L., Deprez F., et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci. 2011; 31 (11): 4037–50. https://doi.org/10.1523/JNEUROSCI.6210-10.2011.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X., Li X., Zhu M., et al. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation. J Neuroinflammation. 2018; 15 (1): 221. https://doi.org/10.1186/s12974-018-1260-z.</mixed-citation><mixed-citation xml:lang="en">Zhu X., Li X., Zhu M., et al. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation. J Neuroinflammation. 2018; 15 (1): 221. https://doi.org/10.1186/s12974-018-1260-z.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ammothumkandy A., Ravina K., Wolseley V., et al. Altered adult neurogenesis and gliogenesis in patients with mesial temporal lobe epilepsy. Nat Neurosci. 2022; 25 (4): 493–503. https://doi.org/10.1038/s41593-022-01044-2.</mixed-citation><mixed-citation xml:lang="en">Ammothumkandy A., Ravina K., Wolseley V., et al. Altered adult neurogenesis and gliogenesis in patients with mesial temporal lobe epilepsy. Nat Neurosci. 2022; 25 (4): 493–503. https://doi.org/10.1038/s41593-022-01044-2.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Patel D.C., Tewari B.P., Chaunsali L., Sontheimer H. Neuron-glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci. 2019; 20 (5): 282–97. https://doi.org/10.1038/s41583-019-0126-4.</mixed-citation><mixed-citation xml:lang="en">Patel D.C., Tewari B.P., Chaunsali L., Sontheimer H. Neuron-glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci. 2019; 20 (5): 282–97. https://doi.org/10.1038/s41583-019-0126-4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Robel S., Buckingham S.C., Boni J.L., et al. Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci. 2015; 35 (8): 3330–45. https://doi.org/10.1523/jneurosci.1574-14.2015.</mixed-citation><mixed-citation xml:lang="en">Robel S., Buckingham S.C., Boni J.L., et al. Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci. 2015; 35 (8): 3330–45. https://doi.org/10.1523/jneurosci.1574-14.2015.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X.X., Yang L., Shao L.X., et al. Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis. J Exp Med. 2020; 217 (1): e20180992. https://doi.org/10.1084/jem.20180992.</mixed-citation><mixed-citation xml:lang="en">Liu X.X., Yang L., Shao L.X., et al. Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis. J Exp Med. 2020; 217 (1): e20180992. https://doi.org/10.1084/jem.20180992.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M.W., Liang X.Y., Wang J., et al. Epilepsy-associated genes: an update. Seizure. 2024; 116: 4–13. https://doi.org/10.1016/j.seizure.2023.09.021.</mixed-citation><mixed-citation xml:lang="en">Zhang M.W., Liang X.Y., Wang J., et al. Epilepsy-associated genes: an update. Seizure. 2024; 116: 4–13. https://doi.org/10.1016/j.seizure.2023.09.021.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Buckmaster P.S., Abrams E., Wen X. Seizure frequency correlates with loss of dentate gyrus GABAergic neurons in a mouse model of temporal lobe epilepsy. J Comp Neurol. 2017; 525 (11): 2592–610. https://doi.org/10.1002/cne.24226.</mixed-citation><mixed-citation xml:lang="en">Buckmaster P.S., Abrams E., Wen X. Seizure frequency correlates with loss of dentate gyrus GABAergic neurons in a mouse model of temporal lobe epilepsy. J Comp Neurol. 2017; 525 (11): 2592–610. https://doi.org/10.1002/cne.24226.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hunt R.F., Girskis K.M., Rubenstein J.L., et al. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat Neurosci. 2013; 16 (6): 692–7. https://doi.org/10.1038/nn.3392.</mixed-citation><mixed-citation xml:lang="en">Hunt R.F., Girskis K.M., Rubenstein J.L., et al. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat Neurosci. 2013; 16 (6): 692–7. https://doi.org/10.1038/nn.3392.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Drexel M., Romanov R.A., Wood J., et al. selective silencing of hippocampal parvalbumin interneurons induces development of recurrent spontaneous limbic seizures in mice. J Neurosci. 2017; 37 (34): 8166–79. https://doi.org/10.1523/JNEUROSCI.3456-16.2017.</mixed-citation><mixed-citation xml:lang="en">Drexel M., Romanov R.A., Wood J., et al. selective silencing of hippocampal parvalbumin interneurons induces development of recurrent spontaneous limbic seizures in mice. J Neurosci. 2017; 37 (34): 8166–79. https://doi.org/10.1523/JNEUROSCI.3456-16.2017.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tan G.H., Liu Y.Y., Hu X.L., et al. Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat Neurosci. 2011; 15 (2): 258–66. https://doi.org/10.1038/nn.3005.</mixed-citation><mixed-citation xml:lang="en">Tan G.H., Liu Y.Y., Hu X.L., et al. Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat Neurosci. 2011; 15 (2): 258–66. https://doi.org/10.1038/nn.3005.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Thind K.K., Yamawaki R., Phanwar I., et al. Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J Comp Neurol. 2010; 518 (5): 647–67. https://doi.org/10.1002/cne.22235.</mixed-citation><mixed-citation xml:lang="en">Thind K.K., Yamawaki R., Phanwar I., et al. Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J Comp Neurol. 2010; 518 (5): 647–67. https://doi.org/10.1002/cne.22235.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Miri M.L., Vinck M., Pant R., Cardin J.A. Altered hippocampal interneuron activity precedes ictal onset. Elife. 2018; 7: e40750. https://doi.org/10.7554/eLife.40750.</mixed-citation><mixed-citation xml:lang="en">Miri M.L., Vinck M., Pant R., Cardin J.A. Altered hippocampal interneuron activity precedes ictal onset. Elife. 2018; 7: e40750. https://doi.org/10.7554/eLife.40750.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kjær C., Barzaghi G., Bak L.K., et al. Transcriptome analysis in patients with temporal lobe epilepsy. Brain. 2019; 142 (10): e55. https://doi.org/10.1093/brain/awz265.</mixed-citation><mixed-citation xml:lang="en">Kjær C., Barzaghi G., Bak L.K., et al. Transcriptome analysis in patients with temporal lobe epilepsy. Brain. 2019; 142 (10): e55. https://doi.org/10.1093/brain/awz265.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Wang H., Liu B., et al. Differential DNA methylation profiles in patients with temporal lobe epilepsy and hippocampal sclerosis ILAE type I. J Mol Neurosci. 2021; 71 (9): 1951–66. https://doi.org/10.1007/s12031-020-01780-9.</mixed-citation><mixed-citation xml:lang="en">Zhang W., Wang H., Liu B., et al. Differential DNA methylation profiles in patients with temporal lobe epilepsy and hippocampal sclerosis ILAE type I. J Mol Neurosci. 2021; 71 (9): 1951–66. https://doi.org/10.1007/s12031-020-01780-9.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Meng X.F., Yu J.T., Song J.H., et al. Role of the mTOR signaling pathway in epilepsy. J Neurol Sci. 2013; 332 (1-2): 4–15. https://doi.org/10.1016/j.jns.2013.05.029.</mixed-citation><mixed-citation xml:lang="en">Meng X.F., Yu J.T., Song J.H., et al. Role of the mTOR signaling pathway in epilepsy. J Neurol Sci. 2013; 332 (1-2): 4–15. https://doi.org/10.1016/j.jns.2013.05.029.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen L.H., Mahadeo T., Bordey A. mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J Neurosci. 2019; 39 (14): 2762–73. https://doi.org/10.1523/JNEUROSCI.2260-18.2019.</mixed-citation><mixed-citation xml:lang="en">Nguyen L.H., Mahadeo T., Bordey A. mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J Neurosci. 2019; 39 (14): 2762–73. https://doi.org/10.1523/JNEUROSCI.2260-18.2019.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pun R.Y., Rolle I.J., Lasarge C.L., et al. Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy. Neuron. 2012; 75 (6): 1022–34. https://doi.org/10.1016/j.neuron.2012.08.002.</mixed-citation><mixed-citation xml:lang="en">Pun R.Y., Rolle I.J., Lasarge C.L., et al. Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy. Neuron. 2012; 75 (6): 1022–34. https://doi.org/10.1016/j.neuron.2012.08.002.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">LaSarge C.L., Pun R.Y.K., Gu Z., et al. mTOR-driven neural circuit changes initiate an epileptogenic cascade. Prog Neurobiol. 2021; 200: 101974. https://doi.org/10.1016/j.pneurobio.2020.101974.</mixed-citation><mixed-citation xml:lang="en">LaSarge C.L., Pun R.Y.K., Gu Z., et al. mTOR-driven neural circuit changes initiate an epileptogenic cascade. Prog Neurobiol. 2021; 200: 101974. https://doi.org/10.1016/j.pneurobio.2020.101974.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Khoshkhoo S., Wang Y., Chahine Y., et al. Contribution of somatic Ras/Raf/mitogen-activated protein kinase variants in the hippocampus in drug-resistant mesial temporal lobe epilepsy. JAMA Neurol. 2023; 80 (6): 578–87. https://doi.org/10.1001/jamaneurol.2023.0473.</mixed-citation><mixed-citation xml:lang="en">Khoshkhoo S., Wang Y., Chahine Y., et al. Contribution of somatic Ras/Raf/mitogen-activated protein kinase variants in the hippocampus in drug-resistant mesial temporal lobe epilepsy. JAMA Neurol. 2023; 80 (6): 578–87. https://doi.org/10.1001/jamaneurol.2023.0473.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">McNamara J.O., Scharfman H.E. Temporal lobe epilepsy and the BDNF receptor, TrkB. In: Noebels J.L., Avoli M., Rogawski M.A., et al. (Eds). Jasper's basic mechanisms of the epilepsies. 4th ed. New York: Oxford University Press; 2024: 1264 pp.</mixed-citation><mixed-citation xml:lang="en">McNamara J.O., Scharfman H.E. Temporal lobe epilepsy and the BDNF receptor, TrkB. In: Noebels J.L., Avoli M., Rogawski M.A., et al. (Eds). Jasper's basic mechanisms of the epilepsies. 4th ed. New York: Oxford University Press; 2024: 1264 pp.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lin T.W., Harward S.C., Huang Y.Z., McNamara J.O. Targeting BDNF/TrkB pathways forpreventing or suppressing epilepsy. Neuropharmacology. 2020; 167: 107734. https://doi.org/10.1016/j.neuropharm.2019.107734.</mixed-citation><mixed-citation xml:lang="en">Lin T.W., Harward S.C., Huang Y.Z., McNamara J.O. Targeting BDNF/TrkB pathways forpreventing or suppressing epilepsy. Neuropharmacology. 2020; 167: 107734. https://doi.org/10.1016/j.neuropharm.2019.107734.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Harward S.C., Huang Y.Z., McNamara J.O. BDNF/TrkB signaling and epileptogenesis. In: Noebels J.L., Avoli M., Rogawski M.A., et al. (Eds). Jasper's basic mechanisms of the epilepsies. 5th ed. New York: Oxford University Press; 2024: 1752 pp.</mixed-citation><mixed-citation xml:lang="en">Harward S.C., Huang Y.Z., McNamara J.O. BDNF/TrkB signaling and epileptogenesis. In: Noebels J.L., Avoli M., Rogawski M.A., et al. (Eds). Jasper's basic mechanisms of the epilepsies. 5th ed. New York: Oxford University Press; 2024: 1752 pp.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Marballi K., MacDonald J.L. Proteomic and transcriptional changes associated with MeCP2 dysfunction reveal nodes for therapeutic intervention in Rett syndrome. Neurochem Int. 2021; 148: 105076. https://doi.org/10.1016/j.neuint.2021.105076.</mixed-citation><mixed-citation xml:lang="en">Marballi K., MacDonald J.L. Proteomic and transcriptional changes associated with MeCP2 dysfunction reveal nodes for therapeutic intervention in Rett syndrome. Neurochem Int. 2021; 148: 105076. https://doi.org/10.1016/j.neuint.2021.105076.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Collins B.E., Neul J.L. Rett syndrome and MECP2 duplication syndrome: disorders of MeCP2 dosage. Neuropsychiatr Dis Treat. 2022; 18: 2813–35. https://doi.org/10.2147/NDT.S371483.</mixed-citation><mixed-citation xml:lang="en">Collins B.E., Neul J.L. Rett syndrome and MECP2 duplication syndrome: disorders of MeCP2 dosage. Neuropsychiatr Dis Treat. 2022; 18: 2813–35. https://doi.org/10.2147/NDT.S371483.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Yi Z., Yang W., Ma Y., et al. Characterization of the relationship of CDKL5 with MeCP2 and Dnmt1 in primary rat cortical neurons. Braz Arch Biol Technol. 2016; 59. https://doi.org/10.1590/1678-4324-2016150510.</mixed-citation><mixed-citation xml:lang="en">Yi Z., Yang W., Ma Y., et al. Characterization of the relationship of CDKL5 with MeCP2 and Dnmt1 in primary rat cortical neurons. Braz Arch Biol Technol. 2016; 59. https://doi.org/10.1590/1678-4324-2016150510.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ehinger Y., Bruyère J., Panayotis N., et al. Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice. EMBO Mol Med. 2020; 12 (2): e10889. https://doi.org/10.15252/emmm.201910889.</mixed-citation><mixed-citation xml:lang="en">Ehinger Y., Bruyère J., Panayotis N., et al. Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice. EMBO Mol Med. 2020; 12 (2): e10889. https://doi.org/10.15252/emmm.201910889.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., He J., Jugloff D.G., Eubanks J.H. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus. 2008; 18 (3): 294–309. https://doi.org/10.1002/hipo.20389.</mixed-citation><mixed-citation xml:lang="en">Zhang L., He J., Jugloff D.G., Eubanks J.H. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus. 2008; 18 (3): 294–309. https://doi.org/10.1002/hipo.20389.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Tao S., Yang X., Chen Y., et al. Up-regulated methyl CpG binding protein-2 in intractable temporal lobe epilepsy patients and a rat model. Neurochem Res. 2012; 37 (9): 1886–97. https://doi.org/10.1007/s11064-012-0804-3.</mixed-citation><mixed-citation xml:lang="en">Tao S., Yang X., Chen Y., et al. Up-regulated methyl CpG binding protein-2 in intractable temporal lobe epilepsy patients and a rat model. Neurochem Res. 2012; 37 (9): 1886–97. https://doi.org/10.1007/s11064-012-0804-3.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Meshkinkhood N., Barati Dowom P., Noorbakhsh F., et al. Unveiling molecular dynamics of MeCp2, CDKL5 and BDNF in the hippocampus of individuals with intractable mesial temporal lobe epilepsy. J Cell Mol Med. 2025; 29 (3): e70373. https://doi.org/10.1111/jcmm.70373.</mixed-citation><mixed-citation xml:lang="en">Meshkinkhood N., Barati Dowom P., Noorbakhsh F., et al. Unveiling molecular dynamics of MeCp2, CDKL5 and BDNF in the hippocampus of individuals with intractable mesial temporal lobe epilepsy. J Cell Mol Med. 2025; 29 (3): e70373. https://doi.org/10.1111/jcmm.70373.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Dogini D.B., Avansini S.H., Vieira A.S., Lopes-Cendes I. MicroRNA regulation and dysregulation in epilepsy. Front Cell Neurosci. 2013; 7: 172. https://doi.org/10.3389/fncel.2013.00172.</mixed-citation><mixed-citation xml:lang="en">Dogini D.B., Avansini S.H., Vieira A.S., Lopes-Cendes I. MicroRNA regulation and dysregulation in epilepsy. Front Cell Neurosci. 2013; 7: 172. https://doi.org/10.3389/fncel.2013.00172.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel G., Saba R., Schratt G. MicroRNAs in neurons: manifold regulatory roles at the synapse. Curr Opin Genet Dev. 2011; 21 (4): 491–7. https://doi.org/10.1016/j.gde.2011.04.008.</mixed-citation><mixed-citation xml:lang="en">Siegel G., Saba R., Schratt G. MicroRNAs in neurons: manifold regulatory roles at the synapse. Curr Opin Genet Dev. 2011; 21 (4): 491–7. https://doi.org/10.1016/j.gde.2011.04.008.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Letellier M., Elramah S., Mondin M., et al. miR-92a regulates expression of synaptic GluA1-containing AMPA receptors during homeostatic scaling. Nat Neurosci. 2014; 17 (8): 1040–2. https://doi.org/10.1038/nn.3762.</mixed-citation><mixed-citation xml:lang="en">Letellier M., Elramah S., Mondin M., et al. miR-92a regulates expression of synaptic GluA1-containing AMPA receptors during homeostatic scaling. Nat Neurosci. 2014; 17 (8): 1040–2. https://doi.org/10.1038/nn.3762.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Aronica E., Fluiter K., Iyer A., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci. 2010; 31 (6): 1100–7. https://doi.org/10.1111/j.1460-9568.2010.07122.x.</mixed-citation><mixed-citation xml:lang="en">Aronica E., Fluiter K., Iyer A., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci. 2010; 31 (6): 1100–7. https://doi.org/10.1111/j.1460-9568.2010.07122.x.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Iyer A., Zurolo E., Prabowo A., et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One. 2012; 7 (9): e44789. https://doi.org/10.1371/journal.pone.0044789.</mixed-citation><mixed-citation xml:lang="en">Iyer A., Zurolo E., Prabowo A., et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One. 2012; 7 (9): e44789. https://doi.org/10.1371/journal.pone.0044789.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Reschke C.R., Henshall D.C. MicroRNA and epilepsy. Adv Exp Med Biol. 2015; 888: 41–70. https://doi.org/10.1007/978-3-319-22671-2_4.</mixed-citation><mixed-citation xml:lang="en">Reschke C.R., Henshall D.C. MicroRNA and epilepsy. Adv Exp Med Biol. 2015; 888: 41–70. https://doi.org/10.1007/978-3-319-22671-2_4.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Simon R., Wiegreffe C., Britsch S. Bcl11 transcription factors regulate cortical development and function. Front Mol Neurosci. 2020; 13: 51. https://doi.org/10.3389/fnmol.2020.00051.</mixed-citation><mixed-citation xml:lang="en">Simon R., Wiegreffe C., Britsch S. Bcl11 transcription factors regulate cortical development and function. Front Mol Neurosci. 2020; 13: 51. https://doi.org/10.3389/fnmol.2020.00051.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Jain S., Zipursky S. Temporal control of neuronal wiring. Semin Cell Dev Biol. 2023; 142: 81–90. https://doi.org/10.1016/j.semcdb.2022.05.012.</mixed-citation><mixed-citation xml:lang="en">Jain S., Zipursky S. Temporal control of neuronal wiring. Semin Cell Dev Biol. 2023; 142: 81–90. https://doi.org/10.1016/j.semcdb.2022.05.012.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lösing P., Niturad C.E., Harrer M., et al. SRF modulates seizure occurrence, activity induced gene transcription and hippocampal circuit reorganization in the mouse pilocarpine epilepsy model. Mol Brain. 2017; 10 (1): 30. https://doi.org/10.1186/s13041-017-0310-2.</mixed-citation><mixed-citation xml:lang="en">Lösing P., Niturad C.E., Harrer M., et al. SRF modulates seizure occurrence, activity induced gene transcription and hippocampal circuit reorganization in the mouse pilocarpine epilepsy model. Mol Brain. 2017; 10 (1): 30. https://doi.org/10.1186/s13041-017-0310-2.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X., Dubey D., Bermudez C., Porter B.E. Suppressing cAMP response element-binding protein transcription shortens the duration of status epilepticus and decreases the number of spontaneous seizures in the pilocarpine model of epilepsy. Epilepsia. 2015; 56 (12): 1870–8. https://doi.org/10.1111/epi.13211.</mixed-citation><mixed-citation xml:lang="en">Zhu X., Dubey D., Bermudez C., Porter B.E. Suppressing cAMP response element-binding protein transcription shortens the duration of status epilepticus and decreases the number of spontaneous seizures in the pilocarpine model of epilepsy. Epilepsia. 2015; 56 (12): 1870–8. https://doi.org/10.1111/epi.13211.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Engel T., Sanz-Rodgriguez A., Jimenez-Mateos E.M., et al. CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures. Brain. 2013; 136 (Pt 2): 577–92. https://doi.org/10.1093/brain/aws337.</mixed-citation><mixed-citation xml:lang="en">Engel T., Sanz-Rodgriguez A., Jimenez-Mateos E.M., et al. CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures. Brain. 2013; 136 (Pt 2): 577–92. https://doi.org/10.1093/brain/aws337.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Cai M., Lin W. Тhe function of NF-kappa B during epilepsy, a potential therapeutic target. Front Neurosci. 2022; 16: 851394. https://doi.org/10.3389/fnins.2022.851394.</mixed-citation><mixed-citation xml:lang="en">Cai M., Lin W. Тhe function of NF-kappa B during epilepsy, a potential therapeutic target. Front Neurosci. 2022; 16: 851394. https://doi.org/10.3389/fnins.2022.851394.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Lubin F.D., Ren Y., Xu X., Anderson A.E. Nuclear factor-kappa B regulates seizure threshold and gene transcription following convulsant stimulation. J Neurochem. 2007; 103 (4): 1381–95. https://doi.org/10.1111/j.1471-4159.2007.04863.x.</mixed-citation><mixed-citation xml:lang="en">Lubin F.D., Ren Y., Xu X., Anderson A.E. Nuclear factor-kappa B regulates seizure threshold and gene transcription following convulsant stimulation. J Neurochem. 2007; 103 (4): 1381–95. https://doi.org/10.1111/j.1471-4159.2007.04863.x.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzuferi M., Kumar G., van Eyll J., et al. Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann Neurol. 2013; 74 (4): 560–8. https://doi.org/10.1002/ana.23940.</mixed-citation><mixed-citation xml:lang="en">Mazzuferi M., Kumar G., van Eyll J., et al. Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann Neurol. 2013; 74 (4): 560–8. https://doi.org/10.1002/ana.23940.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Dreier J.W., Ellis C.A., Berkovic S.F., et al. Epilepsy risk in offspring of affected parents; a cohort study of the “maternal effect” in epilepsy. Ann Clin Transl Neurol. 2021; 8 (1): 153–62. https://doi.org/10.1002/acn3.51258.</mixed-citation><mixed-citation xml:lang="en">Dreier J.W., Ellis C.A., Berkovic S.F., et al. Epilepsy risk in offspring of affected parents; a cohort study of the “maternal effect” in epilepsy. Ann Clin Transl Neurol. 2021; 8 (1): 153–62. https://doi.org/10.1002/acn3.51258.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Oliver K.L., Ellis C.A., Scheffer I.E., et al. Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery. EBioMedicine. 2022; 81: 104079. https://doi.org/10.1016/j.ebiom.2022.104079.</mixed-citation><mixed-citation xml:lang="en">Oliver K.L., Ellis C.A., Scheffer I.E., et al. Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery. EBioMedicine. 2022; 81: 104079. https://doi.org/10.1016/j.ebiom.2022.104079.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Silvennoinen K., Gawel K., Tsortouktzidis D., et al. SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility. Acta Neuropathol. 2022; 144 (1): 107–27. https://doi.org/10.1007/s00401-022-02429-0.</mixed-citation><mixed-citation xml:lang="en">Silvennoinen K., Gawel K., Tsortouktzidis D., et al. SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility. Acta Neuropathol. 2022; 144 (1): 107–27. https://doi.org/10.1007/s00401-022-02429-0.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Kasperaviciute D., Catarino C.B., Matarin M., et al. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain. 2013; 136 (Pt 10): 3140–50. https://doi.org/10.1093/brain/awt233.</mixed-citation><mixed-citation xml:lang="en">Kasperaviciute D., Catarino C.B., Matarin M., et al. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain. 2013; 136 (Pt 10): 3140–50. https://doi.org/10.1093/brain/awt233.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Skotte L., Fadista J., Bybjerg-Grauholm J., et al. Genome-wide association study of febrile seizures implicates fever response and neuronal excitability genes. Brain. 2022; 145 (2): 555–68. https://doi.org/10.1093/brain/awab260.</mixed-citation><mixed-citation xml:lang="en">Skotte L., Fadista J., Bybjerg-Grauholm J., et al. Genome-wide association study of febrile seizures implicates fever response and neuronal excitability genes. Brain. 2022; 145 (2): 555–68. https://doi.org/10.1093/brain/awab260.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Riney K., Bogacz A., Somerville E., et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022; 63 (6): 1443–74. https://doi.org/10.1111/epi.17240.</mixed-citation><mixed-citation xml:lang="en">Riney K., Bogacz A., Somerville E., et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022; 63 (6): 1443–74. https://doi.org/10.1111/epi.17240.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Striano P., Serioli E., Santulli L., et al. DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy. Epilepsia. 2015; 56 (10): e168–71. https://doi.org/10.1111/epi.13094.</mixed-citation><mixed-citation xml:lang="en">Striano P., Serioli E., Santulli L., et al. DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy. Epilepsia. 2015; 56 (10): e168–71. https://doi.org/10.1111/epi.13094.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Dazzo E., Fanciulli M., Serioli E., et al. Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet. 2015; 96 (6): 992–1000. https://doi.org/10.1016/j.ajhg.2015.04.020.</mixed-citation><mixed-citation xml:lang="en">Dazzo E., Fanciulli M., Serioli E., et al. Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet. 2015; 96 (6): 992–1000. https://doi.org/10.1016/j.ajhg.2015.04.020.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Yang H., Yin F., Gan S., et al. The study of genetic susceptibility and mitochondrial dysfunction in mesial temporal lobe epilepsy. Mol Neurobiol. 2020; 57 (9): 3920–30. https://doi.org/10.1007/s12035-020-01993-4.</mixed-citation><mixed-citation xml:lang="en">Yang H., Yin F., Gan S., et al. The study of genetic susceptibility and mitochondrial dysfunction in mesial temporal lobe epilepsy. Mol Neurobiol. 2020; 57 (9): 3920–30. https://doi.org/10.1007/s12035- 020-01993-4.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Thakran S., Guin D., Singh P., et al. Genetic landscape of common epilepsies: advancing towards precision in treatment. Int J Mol Sci. 2020; 21 (20): 7784. https://doi.org/10.3390/ijms21207784.</mixed-citation><mixed-citation xml:lang="en">Thakran S., Guin D., Singh P., et al. Genetic landscape of common epilepsies: advancing towards precision in treatment. Int J Mol Sci. 2020; 21 (20): 7784. https://doi.org/10.3390/ijms21207784.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
